Merck & Co. Inc. buy Royal Bank of Canada
Start price
25.02.26
/
50%
€105.40
Target price
25.02.27
€120.47
Performance (%)
-1.14%
Price
14:14
€104.20
Summary
This prediction is currently active. With a performance of -1.14%, the BUY prediction for Merck & Co. Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 25.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Merck & Co. Inc. | -1.14% |
| iShares Core DAX® | -0,38 % |
| iShares Nasdaq 100 | -0,41 % |
| iShares Nikkei 225® | 1,84 % |
| iShares S&P 500 | -0,71 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (MRK) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat